Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking applications for the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). This award aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. The award will support projects that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly. * The award is open to public and state-controlled institutions of higher education, as well as other eligible applicants. * The award will provide funding for up to 5 years, with an estimated total funding of $650,000. * The application due date is October 19, 2027. * The award is expected to be made in October 2025, with a project start date of December 2025.